DE60032931D1 - Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga - Google Patents

Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga

Info

Publication number
DE60032931D1
DE60032931D1 DE60032931T DE60032931T DE60032931D1 DE 60032931 D1 DE60032931 D1 DE 60032931D1 DE 60032931 T DE60032931 T DE 60032931T DE 60032931 T DE60032931 T DE 60032931T DE 60032931 D1 DE60032931 D1 DE 60032931D1
Authority
DE
Germany
Prior art keywords
vitamin
polypeptides
analogue
screening
cell core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032931T
Other languages
English (en)
Other versions
DE60032931T2 (de
Inventor
Dino Moras
Natacha Rochel
Jean-Marie Wurtz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60032931D1 publication Critical patent/DE60032931D1/de
Application granted granted Critical
Publication of DE60032931T2 publication Critical patent/DE60032931T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60032931T 1999-11-22 2000-11-22 Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga Expired - Lifetime DE60032931T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9914633 1999-11-22
FR9914633A FR2801311B1 (fr) 1999-11-22 1999-11-22 Polypeptides derives du recepteur nucleaire de la vitamine d, et leurs utilisations notamment dans le cadre du criblage d'analogues de la vitamine d
PCT/FR2000/003248 WO2001038393A1 (fr) 1999-11-22 2000-11-22 Polypeptides derives du recepteur nucleaire de la vitamine d, et leurs utilisations notamment dans le cadre du criblage d'analogues de la vitamine d

Publications (2)

Publication Number Publication Date
DE60032931D1 true DE60032931D1 (de) 2007-02-22
DE60032931T2 DE60032931T2 (de) 2007-09-06

Family

ID=9552358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032931T Expired - Lifetime DE60032931T2 (de) 1999-11-22 2000-11-22 Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga

Country Status (9)

Country Link
US (1) US7199219B1 (de)
EP (1) EP1232180B1 (de)
JP (1) JP4124592B2 (de)
AU (1) AU1870001A (de)
CA (1) CA2390898C (de)
DE (1) DE60032931T2 (de)
ES (1) ES2277862T3 (de)
FR (1) FR2801311B1 (de)
WO (1) WO2001038393A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100043432A1 (en) 2008-08-21 2010-02-25 Claudio Filippone Miniaturized waste heat engine
CN116500281B (zh) * 2023-06-26 2023-11-07 天津赛飞乐生物技术有限公司 1,25-二羟基维生素d的检测材料及制备方法、1,25-二羟基维生素d的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6012798A (en) 1997-01-16 1998-08-07 University Of Maryland At College Park, The Genetic methods for identifying individuals for improving well being and perf ormance through exercise
WO1998056908A1 (fr) * 1997-06-13 1998-12-17 Chugai Seiyaku Kabushiki Kaisha Proteines isoformes du recepteur de la vitamine d
AUPO950097A0 (en) * 1997-09-29 1997-10-23 Garvan Institute Of Medical Research Hvdr isoforms
SE9801148D0 (sv) * 1997-10-14 1998-03-31 Pharmacia & Upjohn Ab New receptors
EP1144997A3 (de) * 1998-03-30 2002-08-28 The Regents of the University of California Methoden und verbindungen zur modulation nuklearer rezeptoraktivität

Also Published As

Publication number Publication date
CA2390898A1 (fr) 2001-05-31
EP1232180A1 (de) 2002-08-21
JP2003514579A (ja) 2003-04-22
FR2801311A1 (fr) 2001-05-25
ES2277862T3 (es) 2007-08-01
FR2801311B1 (fr) 2005-08-26
US7199219B1 (en) 2007-04-03
EP1232180B1 (de) 2007-01-10
DE60032931T2 (de) 2007-09-06
AU1870001A (en) 2001-06-04
WO2001038393A1 (fr) 2001-05-31
CA2390898C (fr) 2012-06-19
JP4124592B2 (ja) 2008-07-23

Similar Documents

Publication Publication Date Title
ATE297207T1 (de) 4-benzyl-piperidin-alkylsulfoxid-heterozyklen und ihre verwendung als subtyp-selektive nmda rezeptor antagonisten
ATE342915T1 (de) Chimäres lösliches interleukin-6 rezeptor/ligand protein, analoge und verwendungen
DE69509765T2 (de) N-heterocyclyl sulphonamid-derivate und ihre verwendung als endothelin-antagonisten
ATE425979T1 (de) Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
ATE175666T1 (de) N-(benzofurazanyl)-arylsulfonamide und ihre analoge verwendbar als endothelin-rezeptor- antagonisten
HUP0100266A3 (en) 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations
ATE360070T1 (de) Rezeptor-nukleinsäure und rezeptor-polypeptide
NO20031500L (no) Brodekkepaneler, fremgangsmåte for fremstilling av samme og broer omfattende samme
DE69923510D1 (de) Doppeloberdeck-Flugzeug
DE60000588D1 (de) Ersatzgerät zur biologisch präzisen Simulation der von einem Menschen hervorgerufenen Sitzbelastung
NO20014131D0 (no) Epitoper eller mimotoper avledet fra C-epsilon-3- eller C- epsilon-4-domener fra IgE, antagonister derav og deresterapeutiske anvendelser
ATE412006T1 (de) Anti-retrovirale immunogene, ihre darstellung und verwendung
DE69830913D1 (de) Schablone zum entwurf von personensitzen
DE59709806D1 (de) Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
DE60114413D1 (de) Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten
DE69835433D1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
ATE316968T1 (de) P-thienylbenzyl-amide als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69610316D1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DE68906462T2 (de) Präparat aus Reiskleie und dessen Verwendung.
DE60126614D1 (de) 1,4-diazepan-2,5-dion-derivate und deren verwendung als nk-1 rezeptorantagonisten
ATE292015T1 (de) Reissverschluss und verpackung zu seiner verwendung
WO2001070776A3 (en) Nimr compositions and their methods of use
ATE209626T1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
DE60032931D1 (de) Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga
DE69834174D1 (de) Epidermales protein aus der hornhautschicht und seine verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition